Liaoning Boao Biopharmaceutical

Liaoning Boao Biopharmaceutical is a China-based biopharmaceutical company dedicated to the research, development, and large-scale production of insulin and its analogs. Located in the Benxi High-tech Zone (China Medicine Capital), the company operates advanced manufacturing facilities for recombinant human insulin, insulin aspart, and insulin glargine. Its business model integrates the entire value chain from strain construction and fermentation to purification and final dosage form production. Boao Biopharmaceutical focuses on providing high-quality, affordable therapeutic solutions for the growing population of diabetic patients in China and international markets.